143 related articles for article (PubMed ID: 8721386)
1. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
Kruse-Elliott KT; Albert DH; Summers JB; Carter GW; Zimmerman JJ; Grossman JE
Shock; 1996 Apr; 5(4):265-73. PubMed ID: 8721386
[TBL] [Abstract][Full Text] [Related]
2. Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep.
Snapper JR; Lu W; Lefferts PL; Thabes JS
J Appl Physiol (1985); 1998 May; 84(5):1610-4. PubMed ID: 9572806
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist.
Albert DH; Magoc TJ; Menacherry SD; Morgan DW; Sun E; Reyes AE; Kleinert HD; Carter GW; Summers JB
Inflamm Res; 1997 Jul; 46(7):272-7. PubMed ID: 9266276
[TBL] [Abstract][Full Text] [Related]
4. ABT-299, a potent antagonist of platelet activating factor.
Summers JB; Albert DH; Davidsen SK; Conway RG; Holms JH; Magoc TJ; Luo G; Tapang P; Rhein DA; Carter GW
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():475-7. PubMed ID: 7732895
[No Abstract] [Full Text] [Related]
5. Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
Araújo CV; Barbosa-Filho JM; Cordeiro RS; Tibiriçá E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):267-75. PubMed ID: 11284440
[TBL] [Abstract][Full Text] [Related]
6. Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
Albert DH; Conway RG; Magoc TJ; Tapang P; Rhein DA; Luo G; Holms JH; Davidsen SK; Summers JB; Carter GW
J Pharmacol Exp Ther; 1996 Jun; 277(3):1595-606. PubMed ID: 8667228
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonist.
Albert DH; Magoc TJ; Kleinert HD; Sun E; Reyes AE; Carter GW; Summers JB
Adv Exp Med Biol; 1996; 416():381-7. PubMed ID: 9131177
[No Abstract] [Full Text] [Related]
8. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
Albert DH; Magoc TJ; Tapang P; Luo G; Morgan DW; Curtin M; Sheppard GS; Xu L; Heyman HR; Davidsen SK; Summers JB; Carter GW
Eur J Pharmacol; 1997 Apr; 325(1):69-80. PubMed ID: 9151941
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
10. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
Siebeck M; Weipert J; Keser C; Kohl J; Spannagl M; Machleidt W; Schweiberer L
J Trauma; 1991 Jul; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
[TBL] [Abstract][Full Text] [Related]
11. SK&F 86002, a dual cytokine and eicosanoid inhibitor, attenuates endotoxin-induced cardiopulmonary dysfunction in the pig.
Triplett EA; Kruse-Elliott KT; Hart AP; Schram BR; MacWilliams PS; Cooley AJ; Clayton MK; Darien BJ
Shock; 1996 Nov; 6(5):357-64. PubMed ID: 8946652
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
[TBL] [Abstract][Full Text] [Related]
13. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
Albert DH; Luo G; Magoc TJ; Tapang P; Holms JH; Davidsen SK; Summers JB; Carter GW
Shock; 1996 Aug; 6(2):112-7. PubMed ID: 8856845
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
16. Delayed treatment with platelet activating factor receptor antagonist web 2086 attenuates pulmonary dysfunction in porcine endotoxin shock.
Siebeck M; Kohl J; Endres S; Spannagl M; Machleidt W
J Trauma; 1994 Nov; 37(5):745-51. PubMed ID: 7966471
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats.
Yamano M; Umeda M; Miyata K; Yamada T
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):253-63. PubMed ID: 9750012
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model.
Darien BJ; Fareed J; Centgraf KS; Hart AP; MacWilliams PS; Clayton MK; Wolf H; Kruse-Elliott KT
Shock; 1998 Apr; 9(4):274-81. PubMed ID: 9565256
[TBL] [Abstract][Full Text] [Related]
20. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
Rabinovici R; Esser KM; Lysko PG; Yue TL; Griswold DE; Hillegass LM; Bugelski PJ; Hallenbeck JM; Feuerstein G
Circ Res; 1991 Jul; 69(1):12-25. PubMed ID: 1647275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
